2024, short-term equity securities included our investment in Haleon of $
6.5
billion
.
In the first quarter of 2025, we sold the remaining portion of our investment in Haleon for $
6.3
billion.
(b)
Long-term equity securities of $
132
million as of March 30, 2025 and $
133
million as of December 31, 2024 were held in restricted trusts for U.S. non-qualified employee benefit plans.
(c)
Includes life insurance policies held in restricted trusts for U.S. non-qualified employee benefit plans. The underlying invested assets in these contracts are marketable securities, which are carried at fair value, with changes in fair value recognized in
Other (income)/deductions—net
(see
Note 4
).
Financial Assets and Liabilities Not Measured at Fair Value on a Recurring Basis––
The carrying value of Long-term debt, excluding the current portion, was $
58
billion as of March 30, 2025 and $
57
billion as of December 31, 2024. The estimated fair value of such debt, using a market approach and Level 2 inputs, was $
55
billion as of March 30, 2025 and $
54
billion as of December 31, 2024.
The differences between the estimated fair values and carrying values of held-to-maturity debt securities, private equity securities, long-term receivables and short-term borrowings not measured at fair value on a recurring basis were not significant as of March 30, 2025 and December 31, 2024. The fair value measurements of our held-to-maturity debt securities and short-term borrowings are based on Level 2 inputs. The fair value measurements of our long-term receivables and private equity securities are based on Level 3 inputs.
15
PFIZER INC. AND SUBSIDIARY COMPANIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
B. Investments
Total Short-Term, Long-Term and Equity-Method Investments
(a)
Represent investments in the life sciences sector
.
Debt Securities
Any expected credit losses to these portfolios would be immaterial to our financial statements.
Equity Securities
(a)
Reported in
Other (income)/deductions
––
net.
See
Note 4
.
(b)
Included in net unrealized (gains)/losses are observable price changes on equity securities without readily determinable fair values. As of March 30, 2025, there were cumulative impairments and downward adjustments of $
400
million and upward adjustments of $
223
million. Impairments, downward and upward adjustments were not material to our operations in the first quarters of 2025 and 2024.
16
PFIZER INC. AND SUBSIDIARY COMPANIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
C. Short-Term Borrowings
(a)
Primarily includes cash collateral. See
Note 7F
.
D. Long-Term Debt
E. Derivative Financial Instruments and Hedging Activities
Foreign Exchange Risk––
A significant portion of our revenues, earnings and net investments in foreign affiliates is exposed to changes in foreign exchange rates. Where foreign exchange risk is not offset by other exposures, we manage our foreign exchange risk principally through the use of